U.S. Markets closed

Albany Molecular Research, Inc. (AMRI)


NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
21.71+0.03 (+0.14%)
At close: 4:00PM EDT
People also watch
ARQLARRYALKSENZNANIK
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue570,450402,356276,571
Cost of Revenue437,649296,081210,814
Gross Profit132,801106,27565,757
Operating Expenses
Research Development16,0465,4741,004
Selling General and Administrative122,13677,39447,612
Non Recurring13,3789,75811,417
Others---
Total Operating Expenses---
Operating Income or Loss-18,75913,6495,724
Income from Continuing Operations
Total Other Income/Expenses Net-1,2772,220-235
Earnings Before Interest and Taxes-20,03615,8695,489
Interest Expense39,92319,33810,957
Income Before Tax-59,959-3,469-5,468
Income Tax Expense10,212-1,168-2,190
Minority Interest---
Net Income From Continuing Ops-70,171-2,301-3,278
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-70,171-2,301-3,278
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-70,171-2,301-3,278